300558.SZ Stock Analysis
30
Avoid
Based on Eyestock quantitative analysis, 300558.SZ`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly undervalued
Betta Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of anticancer targeted drugs. The company is headquartered in Hangzhou, Zhejiang and currently employs 1,677 full-time employees. The company went IPO on 2016-11-07. The firm's primary product is its self-developed icotinib hydrochloride (Conmana), a small molecule targeted anticancer drug used for the treatment of lung cancer. The firm is also engaged in promotional services, real estate leasing and other businesses.